文献速递脑血管病帕金森病与运动障碍

低溶酶体酶活性与脑动脉扩张的相关性

Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation.
PubMed 文献 · Stroke · 2018-01-01

在107名帕金森病患者及非血缘对照中,于干血斑测定GLA与GAA酶活性,并由独立阅片者测量海绵窦段颈内动脉升部及基底动脉最近端段的轴位直径。校正线性回归显示,较低的GLA活性与较大的脑动脉直径相关(B=0.50±0.23,P=0.03),其中基底动脉直径关联最强(B=0.80±0.33,P=0.02);较低的GAA活性也与基底动脉直径增大相关(B=0.73±0.35,P=0.04)。

要点

  • 较低GLA活性与较大脑动脉直径相关(B=0.50±0.23,P=0.03)。
  • GLA活性与基底动脉直径关联最强(B=0.80±0.33,P=0.02)。
  • 较低GAA活性与基底动脉直径增大相关(B=0.73±0.35,P=0.04)。

核心结论

  • 较低的GLA和GAA酶活性与较大的脑动脉直径相关,尤其是基底动脉直径。
  • 在无法布里病或庞贝病的患者中,较低的溶酶体酶功能可能在脑动脉扩张中起作用。

研究设计与样本

  • 研究纳入帕金森病患者及非血缘对照,于干血斑测定GLA和GAA酶活性。
  • 由独立阅片者在T2黑血序列上测量海绵窦段颈内动脉升部及基底动脉最近端段的轴位动脉直径。
  • 采用线性回归模型分析脑动脉直径与溶酶体酶活性之间的关系。
  • 队列共107名参与者(平均年龄66.5±10.3岁;67%为男性)。

主要发现

  • 在校正线性回归模型中,较低的GLA活性与较大的脑动脉直径相关(B=0.50±0.23,P=0.03)。
  • GLA活性与基底动脉直径的关联强度最大(B=0.80±0.33,P=0.02)。
  • 较低的GAA活性与基底动脉直径增大相关(B=0.73±0.35,P=0.04)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Absent or diminished α-galactosidase A (GLA) and acid α-glucosidase (GAA) enzyme activity are core features of Fabry and Pompe disease, respectively. Patients with Fabry or Pompe disease may have dilated intracranial arteries but whether lower GLA or GAA enzyme activity relates to brain arterial dilatation in other populations is unknown. Methods- Participants included Parkinson disease patients and nonblood-related controls, whose GLA and GAA enzymatic activities were measured in dried blood spots. Independent readers measured the axial arterial diameter of the ascending portion of the cavernous internal carotid arteries and the most proximal segment of the basilar artery in T2 black voids. Linear regression models were built to investigate the relationship between brain arterial diameters and lysosomal enzymatic activities. Results- The cohort included 107 participants (mean age, 66.5±10.3; 67% men). In an adjusted linear regression model, lower GLA activity was associated with larger brain arterial diameters (B=0.50±0.23, P=0.03). The strength of association was the greatest for the basilar artery diameter (B=0.80±0.33, P=0.02). Similarly, lower GAA activity was associated with an increased basilar arterial diameter (B=0.73±0.35, P=0.04). Conclusions- Lower GLA and GAA enzymatic activities were associated with larger brain arterial diameters, particularly the basilar artery diameter. Lower lysosomal enzymatic function in patients without Fabry or Pompe disease may play a role in brain arterial dilatation.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Shah H, Liong C, Levy OA, et al. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation. Stroke. 2018. PMID: 29986930. doi:10.1161/STROKEAHA.118.021964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。